As summarized in Table S3, rs4801778-T (PLEKHA4) was positively associated with TULP2 expression in LUAD (β = 0.26, P= 9.57E-05), while negatively associated with HSD17B14 expression in PAAD and PRAD (-0.37 < β < -0.36, 1.20E-08 < P < 8.36E-06). Here, PLEKHA4 is linked to prostate adenocarcinoma.